Share this
CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion
Digital Shadows Agrees to Sell to ReliaQuest
Prodege Agrees to Major Investment From Great Hill Partners
Kredivo Agrees to SPAC Merger With VPC Impact Acquisition Holdings II
Nuvation Bio to Combine With Panacea, a Special Purpose Acquisition Company
VelosBio Agrees to Sell to Merck for $2.75 Billion
Forbius Agrees to Sell to Bristol Myers Squibb
Forty Seven Agrees to Sell to Gilead for $4.9 Billion
Synthorx to Sell to Sanofi for $2.5 Billion